SCHEMBL1635307

SCHEMBL1635307

Oc1cccc2ccc(C=Nc3cccc4ccccc34)nc12

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.61
L3MBTL1 Q9Y468 3/20 0.57
POLB P06746 3/20 0.57
MAPT P10636 6/20 0.54
KMT2A Q03164 10/20 0.51
MEN1 O00255 9/20 0.51
ALDH1A1 P00352 3/20 0.51
ATM Q13315 2/20 0.51
GAA P10253 1/20 0.51
DHODH Q02127 2/20 0.51
TDP1 Q9NUW8 3/20 0.48
LMNA P02545 1/20 0.48
NPC1 O15118 5/20 0.47
RAB9A P51151 3/20 0.47
HSP90AA1 P07900 2/20 0.47
AGTR1 P30556 2/20 0.47
CD74 P04233 1/20 0.47
MIF P14174 1/20 0.47
TDP2 O95551 1/20 0.44
THRB P10828 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12725753 1.00 KDM4E (0.61) KDM4EL3MBTL1POLBMAPTKMT2A
SCHEMBL1634970 0.81 MAPT (0.66) KDM4EPOLBMAPTKMT2AMEN1
SCHEMBL12725749 0.81 MAPT (0.66) KDM4EPOLBMAPTKMT2AMEN1
SCHEMBL1635902 0.81 KDM4E (0.67) KDM4EPOLBMAPTKMT2AMEN1
SCHEMBL12725750 0.81 KDM4E (0.67) KDM4EPOLBMAPTKMT2AMEN1
SCHEMBL14280792 0.80 L3MBTL1 (0.54) KDM4EL3MBTL1POLBMAPTKMT2A
SCHEMBL6721105 0.78 KDM4E (0.77) KDM4EL3MBTL1POLBMAPTKMT2A
SCHEMBL4454891 0.77 KDM4E (1.00) KDM4EL3MBTL1POLBMAPTKMT2A
SCHEMBL4454893 0.77 KDM4E (1.00) KDM4EL3MBTL1POLBMAPTKMT2A
SCHEMBL1635015 0.77 KDM4E (0.53) KDM4EL3MBTL1POLBMAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7932331-B2 Polymerisation of ethylene and α-olefins with imino-quinolinol complexes TOTAL PETROCHEMICALS RESEARCH FELUY (BE) 2011-04-26 US disclosed
EP-1994006-B1 POLYMERISATION OF ETHYLENE AND ALPHA-OLEFINS WITH IMINO-QUINOLINOL COMPLEXES TOTAL PETROCHEMICALS RES FELUY (BE) 2010-11-17 EP disclosed
US-20100004411-A1 POLYMERISATION OF ETHYLENE AND ALPHA-OLEFINS WITH IMINO-QUINOLINOL COMPLEXES TOTAL PETROCHEMICALS RESEARCH FELUY (BE) 2010-01-07 US disclosed
EP-1832579-A1 Polymerisation of ethylene and alpha-olefins with imino-quinolinol complexes TOTAL PETROCHEMICALS RESEARCH FELUY (BE) 2007-09-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100004411-A1 POLYMERISATION OF ETHYLENE AND ALPHA-OLEFINS WITH IMINO-QUINOLINOL COMPLEXES UBE2L3, PCNA, UBE2L6 KDM4E 3956/4885L3MBTL1 3862/4885POLB 165/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.